Nouveau Global Ventures 38th AGM: All 4 resolutions pass with over 99.9 percent approval

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Reaction day

₹0.32

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.0%-0.0% vs market

Trading & Distributors peers, median of 133sector+0.0%+0.0% vs sector

On the reaction day the stock moved in line with Nifty Microcap 250 and in line with its Trading & Distributors peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.0+0.0-0.0+0.0+0.0

Next day

+0.0+1.3-1.3-0.1+0.1

+6.3+1.1+5.2-0.6+6.8

+3.1-1.7+4.8-2.3+5.4

+0.0-1.4+1.4-2.9+2.9

+3.1-0.6+3.7-2.3+5.4

+3.1+0.3+2.8-1.3+4.4

15d

+3.1-6.1+9.2-4.8+7.9

—————

UpDownMarket · Nifty Microcap 250Sector · Trading & Distributors peers, median of 133Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Nouveau Global Ventures held its 38th AGM on 29 Sep 2026 via video conferencing. All 4 resolutions passed with over 99.9 percent approval: FY26 financials adoption (99.997 percent), re-appointment of Mr. Krishan Khadaria as director retiring by rotation (99.918 percent) and as Managing Director, a special resolution (99.908 percent), and related party transactions (99.918 percent). 53 of 24,732 shareholders attended via VC. Promoters with 60.69 lakh shares abstained on interested resolutions. Public voting turnout was about 9.8 percent.

Likely market impact

Routine procedural outcome. Managing Director re-appointment and related party transactions cleared comfortably. No material impact on shareholders expected.